Rosen Law Firm is urging Enphase Energy investors who purchased securities between April 22, 2025 and October 28, 2025 and suffered losses exceeding $100,000 to seek legal counsel before the April 20, 2026 lead plaintiff deadline. The lawsuit alleges that Enphase made false statements regarding its channel inventory management, ability to mitigate effects from the termination of the Residential Clean Energy Credit, and overall financial prospects.

Kahn Swick & Foti, LLC announced multiple class action securities lawsuits against Enphase Energy, Soleno Therapeutics, and Navan Inc. for alleged securities fraud. Enphase is accused of overstating inventory management capabilities and financial prospects during April-October 2025. Investors have until specified deadlines to apply as lead plaintiffs.

Enphase Energy announced it will host a conference call on April 28, 2026 at 4:30 p.m. ET to discuss its first quarter 2026 financial results. The company, a global leader in microinverter-based solar and battery systems, has shipped approximately 86.4 million microinverters with over 5.1 million systems deployed across 160 countries.

A securities class action has been filed against Enphase Energy (NASDAQ: ENPH) for allegedly failing to adequately disclose specific operational problems while relying on generic risk warnings. The lawsuit claims management knew about rising channel inventory above targets, pulled forward revenue to mask demand weakness, and overstated mitigation of tax credit impacts. Shares fell 15.15% after these issues surfaced, with Q4 2025 guidance significantly missing analyst estimates.

A securities class action lawsuit has been filed against Enphase Energy, Inc. (ENPH) for allegedly making false statements about its ability to manage channel inventory and mitigate the effects of the expiration of the Residential Clean Energy Credit. The company's stock fell over 15% on October 28, 2025, when it disclosed elevated inventory and negative revenue impacts. Investors who purchased ENPH securities between April 22, 2025 and October 28, 2025 can seek appointment as lead plaintiff by April 20, 2026.

A securities class action lawsuit has been filed against Enphase Energy, Inc. (ENPH) alleging the company made false and misleading statements regarding its channel inventory management, ability to mitigate effects from the termination of the Residential Clean Energy Credit, and overall financial prospects. Investors who purchased ENPH securities between April 22, 2025 and October 28, 2025 may be eligible for compensation. The lead plaintiff deadline is April 20, 2026.

The Schall Law Firm is seeking investors who purchased Enphase Energy securities between April 22, 2025 and October 28, 2025 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements regarding its ability to manage channel inventory and misstated its capability to manage the impact of the termination of the Residential Clean Energy Credit.

Kahn Swick & Foti, LLC announced multiple class action securities fraud lawsuits against Enphase Energy, Soleno Therapeutics, and Kyndryl Holdings. Enphase faces allegations of overstating inventory management capabilities and financial prospects between April-October 2025, with an April 20, 2026 deadline for lead plaintiff applications. Similar lawsuits were filed against Soleno (May 5, 2026 deadline) and Kyndryl (April 13, 2026 deadline).

Kahn Swick & Foti, LLC announced class action securities lawsuits against three companies for alleged material misstatements and omissions. Gemini Space Station is accused of overstating its crypto platform viability and international expansion prospects. Soleno Therapeutics and Enphase Energy also face similar securities fraud allegations. Investors have until specified deadlines to apply as lead plaintiffs.

Rosen Law Firm is encouraging investors who purchased Enphase Energy (ENPH) securities between April 22, 2025 and October 28, 2025 to join a class action lawsuit. The lawsuit alleges that Enphase made false and misleading statements regarding its ability to manage channel inventory, mitigate effects from the termination of the Residential Clean Energy Credit, and overstated its financial and operational prospects. The lead plaintiff deadline is April 20, 2026.

Rosen Law Firm has filed class action lawsuits against Concorde International Group Ltd. (CIGL), Enphase Energy Inc. (ENPH), and Corcept Therapeutics Incorporated (CORT) on behalf of investors who purchased securities during specified periods in 2025. The lawsuits allege false statements, misleading disclosures, and fraudulent schemes. Investors have until May 20, 2026 to move the court to serve as lead plaintiff.

Rosen Law Firm is soliciting investors for multiple securities class action lawsuits. The primary case involves Corcept Therapeutics, where investors who purchased stock between October 31, 2024 and December 30, 2025 may be eligible for compensation. The lawsuit alleges that Corcept misrepresented clinical trial data and FDA communications regarding its relacorilant drug approval prospects, when the FDA had actually raised concerns about the evidence. The lead plaintiff deadline is April 21, 2026.